Page results
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
Exhibition co-curated by Healthcare Arts Collective and UCLH Arts and Heritage 25th August - 20th October 2021, UCH Street Gallery, 235 Euston Road
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.
File results
-
FOI/2021/0644 - Clinical guidelines on identification and management of maternity issues
-
FOI/2021/0645 - Software suppliers for various applications
-
FOI/2021/0649 - Physiotherapists/ occupational therapists staffing levels
-
FOI/2021/0650 - Cyber Essentials Accreditation/ Certification
-
FOI/2021/0657 - Patient list for Neuropsychiatry
-
FOI/2021/0653 - Patient Quality Safety Committee in July 2021
-
FOI/2021/0672 - Long Covid statistics
-
FOI/2021/0691 - MHPS investigations
-
FOI/2021/0700 - Treatment of rare diseases
-
FOI/2021/0705 - Trust's maternity services